Kura Oncology KURA Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's change in other liabilities?
- Kura Oncology (KURA) reported change in other liabilities of $204K in Q1 2026.
- How has Kura Oncology's change in other liabilities changed year-over-year?
- Kura Oncology's change in other liabilities decreased by 21.2% year-over-year, from $259K to $204K.
- What is the long-term trend for Kura Oncology's change in other liabilities?
- Over 2 years (2023 to 2025), Kura Oncology's change in other liabilities has grown at a 175.9% compound annual growth rate (CAGR), from $137K to $1.04M.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.